Structure

InChI Key XRECTZIEBJDKEO-UHFFFAOYSA-N
Smile Nc1[nH]c(=O)ncc1F
InChI
InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)

Physicochemical Descriptors

Property Name Value
Molecular Formula C4H4FN3O
Molecular Weight 129.09
AlogP -0.51
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 0.0
Polar Surface Area 71.77
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 9.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Thymidylate synthase inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - -
Enzyme Transferase
- - - - 8.805-18.73
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - -7.17-3.23
Other cytosolic protein
711 - - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Infections 4 D007239 ClinicalTrials
Intracranial Hypertension 2 D019586 ClinicalTrials
Meningitis, Cryptococcal 2 D016919 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Brain Neoplasms 1 D001932 ClinicalTrials
Digestive System Neoplasms 1 D004067 ClinicalTrials
Carcinoma, Hepatocellular 1 D006528 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Astrocytoma 1 D001254 ClinicalTrials
Oligodendroglioma 1 D009837 ClinicalTrials
Gliosarcoma 1 D018316 ClinicalTrials
Colorectal Neoplasms 1 D015179 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Infections and infestations
12.44
Investigations
10.45
Metabolism and nutrition disorders
10.45
Respiratory, thoracic and mediastinal disorders
8.96
General disorders and administration site conditions
8.46
Gastrointestinal disorders
6.97
Blood and lymphatic system disorders
5.97
Congenital, familial and genetic disorders
4.48
Injury, poisoning and procedural complications
4.48
Skin and subcutaneous tissue disorders
3.98
Nervous system disorders
3.48
Musculoskeletal and connective tissue disorders
2.99
Psychiatric disorders
2.99
Vascular disorders
2.99
Renal and urinary disorders
2.49

Cross References

Resources Reference
CAS NUMBER 2022-85-7
ChEBI 5100
ChEMBL CHEMBL1463
DrugBank DB01099
DrugCentral 1188
EPA CompTox DTXSID3023059
FDA SRS D83282DT06
Human Metabolome Database HMDB15231
PDB 1LD
PharmGKB PA449654
PubChem 3366
SureChEMBL SCHEMBL24063
ZINC ZINC000000896546